https://www.selleckchem.com/
BACKGROUND Placental or breast milk maternal antibodies can potentially reduce oral rotavirus vaccine efficacy in developing countries. We aimed to examine the relationship between the level of rotavirus specific immunoglobulin A (IgA) and neutralising antibodies (NA) in colostrum and breast milk and cord IgG, with cumulative vaccine take following one and three doses of oral RV3-BB rotavirus vaccine within a Phase IIb trial in Indonesia. METHODS 196 infants received three doses of RV3-BB in a randomized, double-blinded trial, using a neonatal schedule (fir
إعجاب
علق
شارك
